Findings seen in two cohorts of older adults with different sociodemographic characteristics
FRIDAY, May 28, 2021 (HealthDay News) — Tetanus, diphtheria, pertussis (Tdap) vaccination in older adults is associated with a 42 percent lower dementia risk, according to a study recently published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.
Jeffrey F. Scherrer, Ph.D., from Saint Louis University, and colleagues assessed whether Tdap vaccination is associated with incident dementia. The analysis included a Veterans Health Affairs (VHA) cohort (96 percent male; 91.2 percent White) and a MarketScan medical claims cohort of older adults (65.4 percent female) free of dementia for two years before the index period (2011 or 2012), with follow-up through 2018.
The researchers found that after controlling for confounding variables, patients with Tdap vaccination had a significantly lower risk for dementia in both cohorts (VHA: hazard ratio, 0.58; MarketScan: hazard ratio, 0.58) compared with older adults without Tdap vaccination.
“Several vaccine types are linked to decreased dementia risk, suggesting that these associations are due to nonspecific effects on inflammation rather than vaccine-induced pathogen-specific protective effects,” the authors write.
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Study IDs Dementia Risk Factors in Those Older Than 90 Years 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia 
Food-Based Support Aids Type 2 Diabetes Outcomes 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines .jpg)
Hispanic Patients Face Delays in Frontotemporal Dementia Diagnosis 
